16.11.2021 (Lehdistötiedote on englanniksi)
Aiforia achieves CE-IVD mark for clinical PD-L1 AI model in lung cancer diagnostics
Aiforia announces the CE-IVD mark of its Aiforia® Clinical AI Model for Lung Cancer; PD-L1 for assisting pathologists in the fast and accurate primary diagnosis of lung cancer. This latest AI model expands Aiforia’s portfolio of clinical diagnostics solutions for pathology.

16.9.2021 (Lehdistötiedote on englanniksi)
Aiforia Announces Closing of €17.5M Series B Funding Round
Financing to accelerate Aiforia’s development and continuing expansion of AI solutions for image analysis in clinical diagnostics and preclinical pathology.